agilon health, inc. Stockholders Equity

Quick Answer

agilon health, inc. reported Stockholders Equity of $470.95 million for the year ending 2024.

  • agilon health, inc. showed a decrease of -28.8% in Stockholders Equity from 2023 to 2024.
  • This data is from agilon health, inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2025.
  • XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2021: -$298.17 million | Q2 2021: $1.15 billion | Q3 2021: $1.13 billion | Q1 2022: $1.11 billion | Q2 2022: $1.10 billion | Q3 2022: $1.09 billion | Q1 2023: $1.08 billion | Q2 2023: $880.17 million | Q3 2023: $872.37 million | Q1 2024: $689.27 million | Q2 2024: $676.64 million | Q3 2024: $574.87 million.
  • Over the full 5 years of available data (2020 to 2024), agilon health, inc.'s Stockholders Equity has grown by 265.4%.
  • Historical annual values: Fiscal year 2024: $470.95 million | Fiscal year 2023: $661.84 million | Fiscal year 2022: $1.04 billion | Fiscal year 2021: $1.09 billion | Fiscal year 2020: -$284.73 million.
  • Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: